November, 2022

Real-World Utilization of Immune Globulin Subcutaneous 16.5% in Treatment-Naïve Primary Immunodeficient Patients

Nov 14, 2022 | Clinical Outcomes

Presented at ACAAI 2022 Authors: Jeffrey W. Langford, MD, AE-C Richard F. Herrscher, MD, FACAAI Dawn N. Kim-Romo, PharmD, PhD Lucinda J. Van Anglen, PharmD View Poster

Real-World Utilization of Immune Globulin Intravenous 10% at Physician Office Infusion Centers

Nov 14, 2022 | Clinical Outcomes

Presented at ACAAI 2022 Authors: Richard F. Herrscher, MD, FACAAI Quyen Luu, MD Dawn N. Kim-Romo, PharmD, PhD Lucinda J. Van Anglen, PharmD View Poster

Real-World Utilization of Immune Globulin Subcutaneous 16.5% in Treatment-Naïve Primary Immunodeficient Patients

Real-World Utilization of Immune Globulin Intravenous 10% at Physician Office Infusion Centers

Recent Posts

Recent Comments

Archives

Categories

Meta